The World Federation of Socleties of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part II: Treatment of mania

Heinz Grunze, Siegfried Kasper, Guy Goodwin, Charles Bowden, David Baldwin, Rasmus W. Licht, Eduard Vieta, Hans Jürgen Möller

Research output: Contribution to journalReview articlepeer-review

157 Scopus citations

Abstract

Identical to the preceding guidelines of this series, these practice guidelines for the biological, mainly pharmacological treatment of acute bipolar mania were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). Their purpose is to supply a systematic overview of all scientific evidence pertaining to the treatment of acute mania. The data used for these guidelines have been extracted from a MEDLINE and EMBASE search, from recent proceedings of key conferences, and from various national and international treatment guidelines. Their scientific rigor was categorised into four levels of evidence (A-D). As these guidelines are intended for clinical use, the scientific evidence was finally not only graded, but has also been commented by the experts of the task force to ensure practicability.

Original languageEnglish (US)
Pages (from-to)5-13
Number of pages9
JournalWorld Journal of Biological Psychiatry
Volume4
Issue number1
DOIs
StatePublished - 2003

Keywords

  • acute treatment
  • antipsychotics
  • bipolar disorder
  • electroconvulsive therapy
  • evidence-based guidelines
  • mania
  • mood stabiliser
  • pharmacotherapy

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Fingerprint Dive into the research topics of 'The World Federation of Socleties of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part II: Treatment of mania'. Together they form a unique fingerprint.

Cite this